Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?

To: R Sandvig who wrote (615)	5/4/1998 10:27:00 PM
From: timothy alan morris	Respond to of 849

A cure for cancer is useless if you cannot identify those who have it. Any treatment is more effective if begun early. It would seem that those companies that can develop more effective means of screening and identifying those who need treatment (ie NMPS) would benefit by the development of more effective treatments. I too was somewhat perplexed by today's price movement considering the news of the day. However, I'm sure there are hundreds of shareholders of another small biotech co. who, having been richly rewarded today, are glad they had the patience to hold-on. We may be next. Always holding, Tim